Home > Products > CD3 & CLEC12A
> Recombinant Anti-CD3 x Anti-CLEC12A Bispecific Antibody (IgG-Fv)
Recombinant Anti-CD3 x Anti-CLEC12A Bispecific Antibody (IgG-Fv) (CAT#: BSGV-073)
Recombinant Anti-CD3 x Anti-CLEC12A Bispecific Antibody (IgG-Fv) is formed by an Immunoglobulin G (IgG) and a fragment variable Fv region, in which the Fc of IgG is engineered by KIH. The Fv region of an anti-CD3 antibody variable domain is fused to the C terminal of an IgG of anti-CLEC12A antibody, or vice versa. The format retains desired characteristics of intact antibodies. This BsAb can retarget T cells to tumor cells. It is designed for the research of Acute myeloid leukemia (AML); Myelodysplastic syndromes (MDS); Chronic myelogenous leukemia (CML) therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD3 x Anti-CLEC12A Bispecific Antibody (IgG-Fv) (BSGV-073). Click the button below to contact us or submit your feedback about this product.